StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform

DURHAM, N.C., June 13, 2018 /PRNewswire/ — StrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies … …read more

Read more here:: StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform

      

You must be logged in to post a comment.